Skip to main content
SpringerLink
Log in

Iodine and Graves’ Disease

  • Chapter
Graves’ Disease

Part of the book series: Endocrine Updates ((ENDO,volume 6))

  • 321 Accesses

Abstract

The thyroid is able to adjust to available plasma iodide levels and maintain normal thyroid function by an intrinsic thyroidal mechanism that is independent of changes in thyroid stimulating hormone (TSH). This ability of the thyroid to regulate hormone synthesis is known as autoregulation. Iodide has two potentially adverse effects on the thyroid — inhibition of thyroid hormone synthesis and inhibition of thyroid hormone release.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wolff J, Chaikoff IL 1948 Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174:555–564

    PubMed  CAS  Google Scholar 

  2. Raben MS 1949 The paradoxical effects of thiocyanate and of thyroglobulin on the organic binding of iodine by the thyroid in the presence of large amounts of iodide. Endocrinology 45:296–304

    Article  PubMed  CAS  Google Scholar 

  3. Nagataki S, Ingbar SH 1964 Relation between qualitative and quantitative alterations in thyroid hormone synthesis induced by varying doses of iodide. Endocrinol 74:731–736

    Article  CAS  Google Scholar 

  4. Dugrillon A 1996 Iodolactones and iodoaldehydes—mediators of iodine in thyroid autoregulation. Exp Clin Endocrinol Diabetes 104 Suppl 4:41–45

    Article  PubMed  CAS  Google Scholar 

  5. Wolff J, Chaikoff IL, Goldberg RC, Meier JR 1949 The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinol 45:504–513

    Article  CAS  Google Scholar 

  6. Braverman LE, Ingbar SH 1963 Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest 42:1216–1231

    Article  PubMed  CAS  Google Scholar 

  7. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379:458–460

    Article  PubMed  CAS  Google Scholar 

  8. Eng PHK, Cardona GR, Fang S-L, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE 1999 Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140:3404–3410

    Article  PubMed  CAS  Google Scholar 

  9. Nagataki S, Yokoyama N 1990 Autoregulation: effects of iodine. Acta Med Austriaca 17 Suppl 1:4–8

    Google Scholar 

  10. Vagenakis AG, Downs P, Braverman LE, Burger A, Ingbar SH 1973 Control of thyroid hormone secretion in normal subjects receiving iodides. J Clin Invest 52:1010–1017

    Article  PubMed  Google Scholar 

  11. Safran M, Braverman LE 1982 Effect of chronic douching with polyvinylpyrrolidone-iodine on iodine absorption and thyroid function. Obstet Gynecol 60:35–40

    PubMed  CAS  Google Scholar 

  12. Ader AW, Paul TL, Reinhardt W, Safran M, Pino S, McArthur W, Braverman LE 1988 Effect of mouth rinsing with two polyvinylpyrrolidone-iodine mixtures on iodine absorption and thyroid function. J Clin Endocrinol Metab 66:632–635

    Article  PubMed  CAS  Google Scholar 

  13. Philippou G, Koutras DA, Piperingos G, Souvatzoglou A, Moulopoulos SD 1992 The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin Endocrinol (Oxf) 36:573–578

    Article  CAS  Google Scholar 

  14. LeMar H J, Georgitis WJ, McDermott MT 1995 Thyroid adaptation to chronic tetraglycine hydroperiodide water purification tablet use. J Clin Endocrinol Metab 80:220–223

    Article  PubMed  CAS  Google Scholar 

  15. Namba H, Yamashita S, Kimura H, Yokoyama N, Usa T, Otsuru A, Izumi M, Nagataki S 1993 Evidence of thyroid volume increase in normal subjects receiving excess iodide. J Clin Endocrinol Metab 76:605–608

    Article  PubMed  CAS  Google Scholar 

  16. Arntzenius AB, Smit LJ, Schipper J, van der Heide D, Meinders AE 1991 Inverse relation between iodine intake and thyroid blood flow: color Doppler flow imaging in euthyroid humans. J Clin Endocrinol Metab 73:1051–1055

    Article  PubMed  CAS  Google Scholar 

  17. Paul T, Meyers B, Witorsch RJ, Pino S, Chipkin S, Ingbar SH, Braverman LE 1988 The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metabolism 37:121–124

    Article  PubMed  CAS  Google Scholar 

  18. Chow CC, Phillips DI, Lazarus JH, Parkes AB 1991 Effect of low dose iodide supplementation on thyroid function in potentially susceptible subjects: are dietary iodide levels in Britain acceptable? Clin Endocrinol (Oxf) 34:413–416

    Article  CAS  Google Scholar 

  19. Gardner DF, Centor RM, Utiger RD 1988 Effects of low dose oral iodide supplementation on thyroid function in normal men. Clin Endocrinol (Oxf) 28:283–288

    Article  CAS  Google Scholar 

  20. Reinhardt W, Luster M, Rudorff KH, Heckmann C, Petrasch S, Lederbogen S, Haase R, Sailer B, Reiners C, Reinwein D, Mann K 1998 Effect of small doses of iodine on thyroid function in patients with Hashimoto’s thyroiditis residing in an area of mild iodine deficiency [see comments]. Eur J Endocrinol 139:23–28

    Article  PubMed  CAS  Google Scholar 

  21. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G 1991 High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves’ disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 229:415–420

    Article  PubMed  CAS  Google Scholar 

  22. Hetzel BS 1989 The story of iodine deficiency-an international challenge in nutrition. Oxford: Oxford Uniiversity Press; 1989.

    Google Scholar 

  23. Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, Vidor G, Braverman LE, Medeiros-Neto G 1998 Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 8:83–100

    Article  PubMed  CAS  Google Scholar 

  24. Adams DD, Kennedy TH, Stewart JC, Utiger RD, Vidor GI 1975 Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin. J Clin Endocrinol Metab 41:221–228

    Article  PubMed  CAS  Google Scholar 

  25. Wilson R, McKillop JH, Thomson JA 1990 The effect of pre-operative potassium iodide therapy on antibody production. Acta Endocrinol (Copenh) 123:531–534

    CAS  Google Scholar 

  26. Weetman AP, McGregor AM, Campbell H, Lazarus JH, Ibbertson HK, Hall R 1983 Iodide enhances IgG synthesis by human peripheral blood lymphocytes in vitro. Acta Endocrinol (Copenh) 103:210–215

    CAS  Google Scholar 

  27. Solomon BL, Evaul JE, Burman KD, Wartofsky L 1987 Remission rates with antithyroid drug therapy: continuing influence of iodine intake? Ann Intern Med 107:510–512

    PubMed  CAS  Google Scholar 

  28. Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE 1993 Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves’ hyperthyroidism. J Clin Endocrinol Metab 76:928–932

    Article  PubMed  CAS  Google Scholar 

  29. Smith A, McKenna TJ 1992 Management of patients with diffuse toxic goitre in Ireland, a country with low iodine intake. Ir J Med Sci 161:597–599

    Article  PubMed  CAS  Google Scholar 

  30. Benker G, Reinwein D, Kahaly G, Tegler L, Alexander WD, Fassbinder J, Hirche H 1998 Is there a methimazole dose effect on remission rate in Graves’ disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs. Clin Endocrinol (Oxf) 49:451–457

    Article  CAS  Google Scholar 

  31. Schuppert F, Taniguchi S, Schroder S, Dralle H, von zur Mühlen A, Kohn LD 1996 In vivo and in vitro evidence for iodide regulation of major histocompatibility complex class I and class II expression in Graves’ disease. J Clin Endocrinol Metab 81:3622–3628

    Article  PubMed  Google Scholar 

  32. Taniguchi SI, Shong M, Giuliani C, Napolitano G, Saji M, Montani V, Suzuki K, Singer DS, Kohn LD 1998 Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF- kappa B. Mol Endocrinol 12:19–33

    Article  PubMed  CAS  Google Scholar 

  33. Wu SY, Chopra IJ, Solomon DH, Bennett LR 1978 Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. J Clin Endocrinol Metab 46:691–697

    Article  PubMed  CAS  Google Scholar 

  34. Laurberg P, Boye N 1987 Inhibitory effect of various radiographic contrast agents on secretion of thyroxine by the dog thyroid and on peripheral and thyroidal deiodination of thyroxine to tri-iodothyronine. J Endocrinol 112:387–390

    Article  PubMed  CAS  Google Scholar 

  35. Felicetta JV, Green WL, Nelp WB 1980 Inhibition of hepatic binding of thyroxine by cholecystographic agents. J Clin Invest 65:1032–1040

    Article  PubMed  CAS  Google Scholar 

  36. Roti E, Robuschi G, Manfredi A, L DA, Gardini E, Salvi M, Montermini M, Barlli AL, Gnudi A, Braverman LE 1985 Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves’ disease. Clin Endocrinol (Oxf) 22:489–496

    Article  CAS  Google Scholar 

  37. Wu SY, Shyh TP, Chopra IJ, Solomon DH, Huang HW, Chu PC 1982 Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism. J Clin Endocrinol Metab 54:630–634

    Article  PubMed  CAS  Google Scholar 

  38. Robuschi G, Manfredi A, Salvi M, Gardini E, Montermini M, d’Amato L, Borciani E, Negrotti L, Gnudi A, Roti E 1986 Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves’ disease. J Endocrinol Invest 9:287–291

    PubMed  CAS  Google Scholar 

  39. Brooks MH, Waldstein SS, Bronsky D, Sterling K 1975 Serum triiodothyronine concentration in thyroid storm. J Clin Endocrinol Metab 40:339–341

    Article  PubMed  CAS  Google Scholar 

  40. Ingbar SH 1966 Management of emergencies. IX. Thyrotoxic storm. N Engl J Med 274:1252–1254

    Article  PubMed  CAS  Google Scholar 

  41. McDermott MT, Kidd GS, Dodson LE, Jr., Hofeldt FD 1983 Radioiodine-induced thyroid storm. Case report and literature review. Am J Med 75:353–359

    Article  PubMed  CAS  Google Scholar 

  42. Roth RN, McAuliffe MJ 1989 Hyperthyroidism and thyroid storm. Emerg Med Clin North Am 7:873–883

    PubMed  CAS  Google Scholar 

  43. Yeung SC, Go R, Balasubramanyam A 1995 Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm. Thyroid 5:403–405

    Article  PubMed  CAS  Google Scholar 

  44. Cansler CL, Latham JA, Brown PM, Jr., Chapman WH, Magner JA 1997 Duodenal obstruction in thyroid storm. South Med J 90:1143–1146

    Article  PubMed  CAS  Google Scholar 

  45. Burger AG, Philippe J 1992 Thyroid emergencies. Baillieres Clin Endocrinol Metab 6:77–93

    Article  PubMed  CAS  Google Scholar 

  46. Caldwell G, Errington M, Toft AD 1989 Resistant hyperthyroidism induced by sodium iopodate used as treatment for Graves’ disease. Acta Endocrinol (Copenh) 120:215–216

    CAS  Google Scholar 

  47. Plummer HS 1923 Results of administration of iodine to patients having exopthalmic goitre. JAMA 80:1955

    Google Scholar 

  48. Hamburger JI 1978 Clinical Exercises in Internal Medicine, Vol 1. Thyroid disease Philadelphia: Saunders; 1978.

    Google Scholar 

  49. Hamburger JI 1981 Is there a place for long-term stable iodine in the treatment of Graves’ disease. In: Hambuger JI, Miller JM, eds. Controversies in clinical thyroidology. New York: Springer-Verlag; 1981:159–183.

    Chapter  Google Scholar 

  50. Emerson CH, Anderson AJ, Howard WJ, Utiger RD 1975 Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J Clin Endocrinol Metab 40:33–36

    Article  PubMed  CAS  Google Scholar 

  51. Roti E, Gardini E, Minelli R, Bianconi L, Braverman LE 1993 Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves’ disease. Metabolism 42:403–408

    Article  PubMed  CAS  Google Scholar 

  52. Marigold JH, Morgan AK, Earle DJ, Young AE, Croft DN 1985 Lugol’s iodine: its effect on thyroid blood flow in patients with thyrotoxicosis. Br J Surg 72:45–47

    Article  PubMed  CAS  Google Scholar 

  53. Coy le PJ, Mitchell JE 1982 Thyroidectomy: is Lugol’s iodine necessary? Ann R Coll Surg Engl 64:334–335

    PubMed  CAS  Google Scholar 

  54. Chang DC, Wheeler MH, Woodcock JP, Curley I, Lazarus JR, Fung H, John R, Hall R, McGregor AM 1987 The effect of preoperative Lugol’s iodine on thyroid blood flow in patients with Graves’ hyperthyroidism. Surgery 102:1055–1061

    PubMed  CAS  Google Scholar 

  55. Michie W, Hammer-Hodges DW, Pegg CA, Orr FG, Bewsher PD 1974 Beta-blockade and partial thyroidectomy for thyrotoxicosis. Lancet 1:1009–1011

    Article  PubMed  CAS  Google Scholar 

  56. Toft AD, Irvine WJ, McIntosh D, MacLeod DA, Seth J, Cameron EH, Lidgard GP 1976 Propranolol in the treatment of thyrotoxicosis by subtotal thyroidectomy. J Clin Endocrinol Metab 43:1312–1316

    Article  PubMed  CAS  Google Scholar 

  57. Eriksson M, Rubenfeld S, Garber AJ, Kohler PO 1977 Propranolol does not prevent thyroid storm. N Engl J Med 296:263–264

    Article  PubMed  CAS  Google Scholar 

  58. Feek CM, Sawers JS, Irvine WJ, Beckett GJ, Ratcliffe WA, Toft AD 1980 Combination of potassium iodide and propranolol in preparation of patients with Graves’ disease for thyroid surgery. N Engl J Med 302:883–885

    Article  PubMed  CAS  Google Scholar 

  59. Peden NR, Browning MC, Feely J, Forrest AL, Gunn A, Hamilton WF, Isles TE 1985 The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves’ disease: a comparison of three pre-operative treatment regimens. Q J Med 56:579–591

    PubMed  CAS  Google Scholar 

  60. Berghout A, Wiersinga WM, Brummelkamp WH 1989 Sodium ipodate in the preparation of Graves’ hyperthyroid patients for thyroidectomy. Horm Res 31:256–260

    Article  PubMed  CAS  Google Scholar 

  61. Baeza A, Aguayo J, Barria M, Pineda G 1991 Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol (Oxf) 35:439–442

    Article  CAS  Google Scholar 

  62. Hagen GA, Ouellette RP, Chapman EM 1967 Comparison of high and low dosage levels of 131–I in the treatment of thyrotoxicosis. N Engl J Med 277:559–562

    Article  PubMed  CAS  Google Scholar 

  63. Schimmel M, Utiger RD 1977 Acute effect of inorganic iodide after 131I therapy for hyperthyroidism. Clin Endocrinol (Oxf) 6:329–332

    Article  CAS  Google Scholar 

  64. Taylor JD, Radcliffe SN, Basu PK, Atkins P 1993 Iodine therapy for thyroidectomy patients exhibiting high thyroid- stimulating hormone values: a randomised study. Ann RColl Surg Engl 75:168–171

    CAS  Google Scholar 

  65. Bazzi MN, Bagchi N 1993 Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves’ disease. Thyroid 3:269–272

    Article  PubMed  CAS  Google Scholar 

  66. Braverman LE, Woeber KA, Ingbar SH 1969 Induction of myxedema by iodide in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goiter. N Engl J Med 281:816–821

    Article  PubMed  CAS  Google Scholar 

  67. Roti E, Gnudi A, Braverman LE 1983 The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 4:131–149

    Article  PubMed  CAS  Google Scholar 

  68. 1993 Thyroid disease in pregnancy. ACOG Technical Bulletin Number 181—June 1993. Int J Gynaecol Obstet 43:82–88

    Google Scholar 

  69. Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K 1992 Effects of iodine on thyroid status of fetus versus mother in treatment of Graves’ disease complicated by pregnancy. J Clin Endocrinol Metab 75:738–744

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Peter H. K. Eng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lewis E. Braverman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Autoimmune Disease Unit, Cedars-Sinai Research Institute and U.C.L.A. School of Medicine, Los Angeles, California, USA

    Basil Rapoport M.B., Ch.B.  & Sandra M. McLachlan Ph.D  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Eng, P.H.K., Braverman, L.E. (2000). Iodine and Graves’ Disease. In: Rapoport, B., McLachlan, S.M. (eds) Graves’ Disease. Endocrine Updates, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4407-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4407-4_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6983-7

  • Online ISBN: 978-1-4615-4407-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation